Optimal effect of Lactobacillus delbruecki subsp. bulgaricus, among other lactobacilli species, on the number of IgA and mast cells associated with the mucosa in immunosuppressed mice

Food and Agricultural Immunology

Volumn 11, Issue 3, 1999, Pages 259-267

  Bibas Bonet, María E ^b   De Petrino, Silvia F ^b   Mesón, Oscar ^b   De Budeguer, Marta V ^b   Perdiǵn, Gabriela ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b NONE

Author keywords

Bronchus; Gut; IgA secreting cells; Immunosuppression; Lactobacilli; Mast cells

Indexed keywords

IMMUNOGENICITY; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; PATHOGENICITY;

ANIMALIA; BACTERIA (MICROORGANISMS); BRONCHUS; CANDIDA ALBICANS; LACTOBACILLI CASEI; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKI;

EID: 0344604501     PISSN: 09540105     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540109999780     Document Type: Article

References (31)

1. ABRAHAM, S. N. & MALAVIYA, R. (1996) Role of mast cells in bacterial clearance in the lung. Mucosal Immunity Update, Dec., 58-62.
2. BAUS, E., ANDRIS, F., DUBOIS, P. M., URBAN, J. & HO, O. (1996) Dexamethasone inhibits the early steps of antigen receptor signalling in activated T lymphocytes. Journal of Immunology, 12, 4555-4561.
3. BERLAND, R. & WORTIS, H. (1998) The ontogenia and function of B1 cells. Mucosal Immunology Update, 6, 5-10.
4. BISCHOFF, S., LORENTZ, A., SCHWENGBERG, S., WEIER, G., RAAB, R. & MANNS, M. (1999) Mast cells are important cellular source of tumour necrosis factor α in human intestinal tissue, Gut, 44, 643-652.
5. BOUMPAS, D. T., CHROUSOS, G. P., WILDER, R. L., CUPPS, T. R. & BALOW, J. E. (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates, Annals of International Medicine, 12, 1198-1208.
6. BOUMPAS, D. T., PALIOGIANNI, F., ANASTASSIOU, E. D. & BALOW, J. E. (1991 ) Glucocorticoids action on the immune system: molecular and cellular aspects. Clinical and Experimental Rheumatology, 4, 413-423.
7. BRANDTZAEG, P., NICLSEN, O., ROGNUM, T. & THRANE, P. (1991) Ontogeny of the mucosal immune system and IgA deficiency, in Mucosal Immunology: Basic Principles MAC DERMOTT, R. P. & ELSON, E. O. Eds), Gastroenterology Clinics of North America, pp. 397-439.
8. DOUGLAS-BRIGGS, J. (1991) A critical review of immunosuppression therapy. Immunology Reviews, 51, 337-342.
9. EKLUND, K. K., HUMPHRIES, D. E., XIA, Z., GHILDAYAL, N., FRIEND, D. S. GROSS, V. & STEVENS, R. L. (1997) Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases, Journal of Immunology. 9, 4373-4380.
10. GORBACH, S. (1990) Lactic acid bacteria and human health. Annals of Medicine, 22, 1416-1420.
11. HÜLTNER, L., MÄNNEL, D. & ECHTENACHER, B. (1996) Protective role of mast cells in acute septic peritonitis, Mucosal Immunology Update, 4, 56-58.
12. HUNTLEY, J. F. (1992) Mast cells and hasophils: a review of their heterogeneity and function, Journal of Comparative Pathology, 107, 349-372.
13. IWAKI M., OKAHASHI, N., TAKAHASHI, I., KANAMOTO, T., SIGITA-KOMSHI, Y., AIBARA, K. & KOGA, T. (1990) Oral immunisation with recombiliant Streptococcus lactis carring the Streptococcus mutans surface protein antigen gene. Infection and Immunity. 58, 2929-2933.
14. JASUI, H. & OHWAKI, M. (1991) Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium brevis, Journal of Dairy Science, 74, 1187-1195.
15. JOYCE, D. A., STEER, J. H., ABRAHAM, L. J. (1997) Glucocorticoid modulation of human monocyte/macophuge function: control of TNF-alpha secretion, Inflammatory Research, 11, 447-451.
16. KOMATSU, S., GRISHAM, M. B., RUSSELL, J. M. & GRANGER, D. N. (1997) Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice, Gut, 41, 636-641.
17. MCDERMOTT, M. & BIENENSTOCK, J. (1979) Evidence for a common mucosal immunology system migration of B immunoblasts into intestinal, respiratory and gential tissues. Journal of Immunology, 122, 1892-1898.
18. MESTECKY, Y. & MCGHEE, J. R. (1992) Prospect for human mucosal vaccines, Advances in Experimental Medicine and Biology. 327, 13-23.
19. MILLER, E. (1992) Immunosuppressive therapy in the treatment of immune-mediated disease. Journal of Veterinary International Medicine, 4, 206-213.
20. PERDIGON, G. & ALVAREZ, S. (1992) Probiotic and the immune state, in Probiotics: the Scientific Basis (FULLER, R., Ed.), Chapman & Hall, London, pp 145-180.
21. PERDIGON, G., MEDICI, M., BIBAS BONET DE JORRAT, M. E., VALVERDE DE BUDEGUER, M. & PESCE DE RUTZ HOLGADO, A. (1993) Immunomodulation effects of lactic acid bacteria on mucosal and tumoral immunity, International Journal of Immunotherapy, 9, 567-573.
22. PETRINO, S., JORRAT, M. E., MESON, O. & PERDIGON, G. (1995) Protective ability of certain Lactic Acid Bacteria against an infection with Candida albicans in a mouse immunosuppression model by corticoid. Food and Agricultural Immunology, 7, 365-373.
23. PETRINO, S., JORRAT, M. E. & PERDIGON, G. (1996) Effect of different Lactic Acid Bacteria on immune response in corticoid-immunosuppressed mice. Microbiologie Aliments Nutrition, 14, 227-236.
24. PETRINO, S., JORRAT, M. E., BUDEGUER, M. & PERDIGÓN, G. (1997) Influence of the oral administration of different lactic acid bacteria on intestinal microflora and IgA secreting-cells in mice treated with ampicillin, Food and Agricultural Immunology, 9, 265-275.
25. RASMUSSEN, L. & ARVIN, A. (1982) Chemotherapy-induced Immunosuppression. Environment Health Perspectives, 43, 21-29.
26. SPAHN, J. D. & KAMADA, A. K. (1995) Special considerations in the use of glucocorticoids in children. Pediatric Reviews, 7, 266-272.
27. TALAR-WILLIAMS, C. & SNELLER, M. C. (1994) Complications of corticosleroid therapy, European Archives & Otorhinolaryngology, 3, 131-136.
28. TAS, J. (1977) The Alcian Blue and combined Alcian Blue-Safranin staining of glycosaminoglycans studied in a model system and in mast cells, Histochemical Journal, 9, 205-230.
29. VAN COTT, J. BRIM, T. A., LUMEY, J. K., SAIE, L. J. (1994) Contribution of antibody secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of Coronavirus to immunity against enteric Coronavirus challenge. Journal of Immunology, 8, 3980-3990.
30. WEINER, H. (1997) Oral Tolerance: immune mechanisms and treatment of autoimmune disease, Immunology Today, 7, 335-343.
31. WOLOSCHAK, G. E., TOMASI, T. B. (1983) The immunology and molecular biology of the gul associated immune system, Critical Review Immunology, 1, 1-18.